Difference between revisions of "LncRNAWiki:C"
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
− | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] '''C''' [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|''' | + | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] '''C''' [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] |
</div> | </div> | ||
Line 304: | Line 304: | ||
|cysteine and tyrosine rich 1 antisense RNA 1 | |cysteine and tyrosine rich 1 antisense RNA 1 | ||
|N/A | |N/A | ||
+ | |_ | ||
+ | |- | ||
+ | |''CCND2-AS1'' | ||
+ | |[[CCND2-AS1]] | ||
+ | |N/A | ||
+ | |CCND2 antisense RNA 1 | ||
+ | |glioma | ||
+ | |- | ||
+ | |''CD44-AS1'' | ||
+ | |[[CD44-AS1]] | ||
+ | |RP1-68D18.4 | ||
+ | |CD44 antisense RNA 1 | ||
+ | |B cell lymphoma | ||
+ | |- | ||
+ | |''CEBPA-AS1'' | ||
+ | |[[CEBPA-AS1]] | ||
+ | |N/A | ||
+ | |CEBPA antisense RNA 1 (head to head) | ||
+ | |Gastric cancer | ||
+ | |- | ||
+ | |''CERNA1'' | ||
+ | |[[CERNA1]] | ||
+ | |LOC100129973 | ||
+ | |competing endogenous lncRNA 1 for miR-4707-5p and miR-4767 | ||
+ | |cardiovascular disease | ||
+ | |- | ||
+ | |''CERNA2'' | ||
+ | |[[CERNA2]] | ||
+ | |HOST2 | ||
+ | |competing endogenous lncRNA 2 for microRNA let-7b | ||
+ | |Ovarian cancer, Hepatocellular carcinoma | ||
+ | |- | ||
+ | |''CERNA3'' | ||
+ | |[[CERNA3]] | ||
+ | |CTA | ||
+ | |competing endogenous lncRNA 3 for miR-645 | ||
+ | |Osteosarcoma | ||
+ | |- | ||
+ | |''CFLAR-AS1'' | ||
+ | |[[CFLAR-AS1]] | ||
+ | |ALS2CR10 | ||
+ | |CFLAR antisense RNA 1 | ||
+ | |hypertrophic scar | ||
+ | |- | ||
+ | |''CLMAT3'' | ||
+ | |[[CLMAT3]] | ||
+ | |SPARC-AS1 | ||
+ | |colorectal liver metastasis associated transcript 3 | ||
+ | |colorectal cancer | ||
+ | |- | ||
+ | |''CSMD2-AS1'' | ||
+ | |[[CSMD2-AS1]] | ||
+ | |ENST00000434181 | ||
+ | |CSMD2 antisense RNA 1 | ||
+ | |early-onset preeclampsia | ||
+ | |- | ||
+ | |''CYTOR'' | ||
+ | |[[CYTOR]] | ||
+ | |C2orf59, NCRNA00152, LINC00152, MGC4677 | ||
+ | |cytoskeleton regulator RNA | ||
+ | |Breast cancer, Gastric cancer | ||
+ | |- | ||
+ | |''CHMP1B-AS1'' | ||
+ | |[[CHMP1B-AS1]] | ||
+ | |N/A | ||
+ | |CHMP1B antisense RNA 1 | ||
+ | |_ | ||
+ | |- | ||
+ | |''CLLU1'' | ||
+ | |[[CLLU1]] | ||
+ | |N/A | ||
+ | |chronic lymphocytic leukemia up-regulated 1 | ||
|_ | |_ | ||
|} | |} |
Latest revision as of 12:35, 29 June 2017
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
C1QTNF9B-AS1 | C1QTNF9B-AS1 | PCOTH | C1QTNF9B antisense RNA 1 | prostate cancer |
C21orf91-OT1 | C21orf91-OT1 | D21S2089E | C21orf91 overlapping transcript 1 | _ |
C5orf66-AS1 | C5orf66-AS1 | "CTC-276P9.1, Epist" | C5orf66 antisense RNA 1 | esophageal squamous cell carcinoma |
C5orf66-AS2 | C5orf66-AS2 | N/A | C5orf66 antisense RNA 2 | _ |
C8orf34-AS1 | C8orf34-AS1 | N/A | C8orf34 antisense RNA 1 | _ |
CACNA1G-AS1 | CACNA1G-AS1 | N/A | CACNA1G antisense RNA 1 | keloid |
CAHM | ENST00000604200.1 | LINC00468 | colon adenocarcinoma hypermethylated (non-protein coding) | colorectal neoplasia. |
CAPN10-AS1 | CAPN10-AS1 | locus959 | CAPN10 antisense RNA 1 (head to head) | _ |
CAR Intergenic 10 | NONHSAT016928,lnc-FANK1-3:1 | "Intergenic10, CR611911, AK055628" | Chromatin Associated RNA 10 | _ |
CARD8-AS1 | CARD8-AS1 | LOC100505812 | CARD8 antisense RNA 1 | _ |
CARMN | CARMN | CARMEN | cardiac mesoderm enhancer-associated non-coding RNA | _ |
CASC11 | CASC11 | "TCONSN/A00014535, LINC00990, CARLo-7" | cancer susceptibility candidate 11 (non-protein coding) | colorectal cancer |
CASC15 | CASC15 | N/A | cancer susceptibility candidate 15 (non-protein coding) | metastatic melanoma |
CASC19 | CASC19 | CARLo-6 | cancer susceptibility candidate 19 (non-protein coding) | prostate cancer |
CASC2 | CASC2 | N/A | cancer susceptibility candidate 2 (non-protein coding) | colorectal cancer |
CASC21 | CASC21 | CARLo-2 | cancer susceptibility candidate 21 (non-protein coding) | _ |
CASC22 | CASC22 | "TCONSN/A00024290, LincRNA-ENST00000515084" | cancer susceptibility candidate 22 (non-protein coding) | breast cancer |
CASC8 | CASC8 | "LINC00860,CARLo-1" | cancer susceptibility candidate 8 (non-protein coding) | Colorectal Cancer,Lung Cancer |
CASC9 | CASC9 | "LINC00981, ESCCAL-1" | cancer susceptibility candidate 9 (non-protein coding) | predicted esophageal squamous cell carcinoma |
CBR3-AS1 | CBR3-AS1 | PlncRNA-1 | CBR3 antisense RNA 1 | esophageal squamous carcinoma cell |
CCAT1 | NONHSAT129017 | "CARLo-5, onco-lncRNA-40" | colon cancer associated transcript 1 (non-protein coding) | colorectal cancer,gastric cancer |
CCAT2 | CCAT2 | "NCCP1, LINC00873" | colon cancer associated transcript 2 (non-protein coding) | non-small cell lung cancer |
CCDC18-AS1 | CCDC18-AS1 | ENST00000440778.1 | CCDC18 antisense RNA 1 | Adolescent Idiopathic Scoliosis |
CCDC26 | CCDC26 | "MGC27434, RAM" | CCDC26 long non-coding RNA | glioma |
CCEPR | CCEPR | CCHE1 | cervical carcinoma expressed PCNA regulatory lncRNA | cervical cancer |
CDKN1A-AS1 | CDKN1A-AS1 | p21NAT | CDKN1A antisense RNA 1 | _ |
CDKN2B-AS1 | NONHSAT130421,lnc-C9orf53-2:1 | "ANRIL, p15AS, ENSG00000240498" | CDKN2B antisense RNA 1 | abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer, |
CDR1-AS | CDR1-AS | "CDR1NAT, ciRS-7, CDR1as" | CDR1 antisense RNA | _ |
CDRT7 | CDRT7 | "NCRNA00025, LINC00025" | CMT1A duplicated region transcript 7 (non-protein coding) | _ |
CDRT8 | CDRT8 | N/A | CMT1A duplicated region transcript 8 | _ |
CECR3 | CECR3 | N/A | "cat eye syndrome chromosome region, candidate 3 (non-protein coding)" | cat eye syndrome |
CECR5-AS1 | CECR5-AS1 | NCRNA00017 | CECR5 antisense RNA 1 | cat eye syndrome |
CECR7 | CECR7 | SAHL1 | "cat eye syndrome chromosome region, candidate 7 (non-protein coding)" | cat eye syndrome |
CECR9 | CECR9 | N/A | "cat eye syndrome chromosome region, candidate 9 (non-protein coding)" | cat eye syndrome |
CEP83-AS1 | CEP83-AS1 | N/A | CEP83 antisense RNA 1 (head to head) | _ |
CIRBP-AS1 | CIRBP-AS1 | MGC39338 | CIRBP antisense RNA 1 | _ |
CISTR | NONHSAT028496 | "CISTR-ACT, CISTRACT, re52431" | chondrogenesis-associated transcript | _ |
CLRN1-AS1 | CLRN1-AS1 | UCRP | CLRN1 antisense RNA 1 | Usher syndrome type 3 |
COPG2IT1 | COPG2IT1 | "CIT1, NCRNA00170, COPG2AS" | COPG2 imprinted transcript 1 (non-protein coding) | _ |
CPS1-IT1 | CPS1-IT1 | "PRO0132, CPS1-IT" | CPS1 intronic transcript 1 | _ |
CRNDE | Lnc-IRX3-4:2 | "LOC643911, LINC00180, CRNDEP" | colorectal neoplasia differentially expressed (non-protein coding) | colorectal cancer |
CSNK1G2-AS1 | CSNK1G2-AS1 | MGC39696 | CSNK1G2 antisense RNA 1 | _ |
CSTF3-AS1 | CSTF3-AS1 | N/A | CSTF3 antisense RNA 1 (head to head) | _ |
CTBP1-AS | CTBP1-AS | PCAT10 | CTBP1 antisense RNA | prostate cancer |
CTBP1-AS2 | CTBP1-AS2 | MGC21675 | CTBP1 antisense RNA 2 (head to head) | _ |
CYP1B1-AS1 | CYP1B1-AS1 | MGC34824 | CYP1B1 antisense RNA 1 | _ |
CYP4A22-AS1 | ENST00000444042.2 | "Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506" | CYP4A22 antisense RNA 1 | _ |
CYP51A1-AS1 | CYP51A1-AS1 | "ENST00000453068, LRRD1-AS1" | CYP51A1 antisense RNA 1 | renal cell carcinoma |
CYYR1-AS1 | ENST00000357401.3 | cysteine and tyrosine rich 1 antisense RNA 1 | N/A | _ |
CCND2-AS1 | CCND2-AS1 | N/A | CCND2 antisense RNA 1 | glioma |
CD44-AS1 | CD44-AS1 | RP1-68D18.4 | CD44 antisense RNA 1 | B cell lymphoma |
CEBPA-AS1 | CEBPA-AS1 | N/A | CEBPA antisense RNA 1 (head to head) | Gastric cancer |
CERNA1 | CERNA1 | LOC100129973 | competing endogenous lncRNA 1 for miR-4707-5p and miR-4767 | cardiovascular disease |
CERNA2 | CERNA2 | HOST2 | competing endogenous lncRNA 2 for microRNA let-7b | Ovarian cancer, Hepatocellular carcinoma |
CERNA3 | CERNA3 | CTA | competing endogenous lncRNA 3 for miR-645 | Osteosarcoma |
CFLAR-AS1 | CFLAR-AS1 | ALS2CR10 | CFLAR antisense RNA 1 | hypertrophic scar |
CLMAT3 | CLMAT3 | SPARC-AS1 | colorectal liver metastasis associated transcript 3 | colorectal cancer |
CSMD2-AS1 | CSMD2-AS1 | ENST00000434181 | CSMD2 antisense RNA 1 | early-onset preeclampsia |
CYTOR | CYTOR | C2orf59, NCRNA00152, LINC00152, MGC4677 | cytoskeleton regulator RNA | Breast cancer, Gastric cancer |
CHMP1B-AS1 | CHMP1B-AS1 | N/A | CHMP1B antisense RNA 1 | _ |
CLLU1 | CLLU1 | N/A | chronic lymphocytic leukemia up-regulated 1 | _ |